IFCI close to selling part of stake in NSE
.jpg)
IFCI, an Indian state-run lender, might sign an agreement to sell part of its 5.5 per cent stake in the nation's biggest stock exchange in three days.
IFCI is in advanced talks with a foreign private equity fund to sell 1.1 per cent stake in the National Stock Exchange. PricewaterhouseCoopers LLP is helping the Delhi-based company with the sale, Chief Executive Officer Malay Mukherjee said, without disclosing details.
The lender's profitability as measured by the return on common equity has declined for seven straight years and was at 7.7 per cent in the year ended March 31, data compiled by Bloomberg show. IFCI, which initially held a 12.44 per cent stake in the Mumbai-based bourse, in 2007 sold seven per cent to Goldman Sachs Group Inc, NYSE Group Inc, General Atlantic LLC and Softbank Asian Infrastructure Fund.
"If this comes, that would make my balance sheet much healthier as far as the bottom line is concerned," Mukherjee said in an interview on Wednesday.
Shares of IFCI ended 0.3 per cent higher at Rs 37.7 on BSE.
The lender first attempted to sell the stake in October. That was delayed as the bids from investors were below expectations, according to Mukherjee who declined to comment on the valuations sought by the company.
The bourse's other existing investors include Life Insurance Corp. of India, State Bank of India and IDFC. IDBI Bank Ltd, another stakeholder in NSE, is also seeking buyers for its stake of about five per cent, a December 19 advertisement in the newspaper showed.
Other Latest News
.webp)
AAP supremo Arvind Kejriwal on Thursday intensified his criticism of the BJP-led central government, accusing it of failing to ensure law and order in Delhi.
Addressing a press conference at party office, Kejriwal said, "There is an atmosphere of fear and insecurity everywhere in Delhi. Women feel unsafe stepping out after 7 pm and parents worry about their daughters going outside."
.webp)
The High Court on Thursday refused to ban ISKCON's activities in Bangladesh, a local newspaper reported days after a lawyer was killed in a clash between security personnel and supporters of a Hindu leader arrested on sedition charges.
The lawyer had sought a ban from the high court on the International Society for Krishna Consciousness (ISKCON) after placing some newspaper reports related to the organisation on Wednesday.
.webp)
The Manipur government on Thursday announced that classes in schools and colleges in Imphal Valley districts and Jiribam would resume from November 28 after a hiatus of 13 days.
Educational institutes in these districts have remained closed since November 16 after the dead bodies of three women and three children in Jiribam were recovered from the Jiri and Barak rivers in Manipur and Assam respectively.
.webp)
Eknath Shinde, who served as chief minister in the outgoing Maharashtra government, is unlikely to accept the post of deputy CM in the new dispensation, his close aide Sanjay Shirsat said on Thursday.
Shirsat, an MLA and spokesperson of the Shiv Sena, however, said Shinde would be a part of the cabinet.
.webp)
Dr. Reddy’s announced the launch of Toripalimab in India on Thursday, for patients diagnosed with nasopharyngeal carcinoma (NPC), a rare form of head and neck cancer.
Toripalimab, a New Biological Entity (NBE), is the only immuno-oncology drug approved by regulatory authorities like the USFDA, EMA, and MHRA for treating adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). It is globally recognised for its efficacy in this indication, the Hyderabad-based company said in a statement.
.webp)
.webp)
.webp)
.webp)
.webp)
